A Single-dose, Open-label, Randomised, 2-way Crossover, Clinical Pharmacology Study of Four Inhalations of CHF 1535 100/6 NEXT DPI (Fixed Combination of Beclomethasone Diproponate 100 microg Plus Formoterol Fumarate 6 microg) Versus the Same Dose of CHF 1535 100/6 pMDI Both Administered With Charcoal Block.
Phase of Trial: Phase II
Latest Information Update: 04 Apr 2017
At a glance
- Drugs Beclometasone/formoterol (Primary)
- Indications Asthma
- Focus Pharmacokinetics
- 05 Sep 2012 Results presented at the 22nd Annual Congress of the European Respiratory Society.
- 06 Apr 2012 Additional lead trial investigator identified as reported by ClinicalTrials.gov.
- 06 Apr 2012 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
Most Recent Events
Table of Contents
- At a glance
- Trial Overview
- Trial Details
- Trial Centres
- Trial History